Annual Cash & Cash Equivalents
$66.89 M
-$63.22 M-48.59%
31 December 2023
Summary:
Acumen Pharmaceuticals annual cash & cash equivalents is currently $66.89 million, with the most recent change of -$63.22 million (-48.59%) on 31 December 2023. During the last 3 years, it has risen by +$23.11 million (+52.79%). ABOS annual cash & cash equivalents is now -48.59% below its all-time high of $130.10 million, reached on 31 December 2022.ABOS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$33.18 M
-$34.77 M-51.17%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly cash and cash equivalents is currently $33.18 million, with the most recent change of -$34.77 million (-51.17%) on 30 September 2024. Over the past year, it has dropped by -$61.73 million (-65.04%). ABOS quarterly cash and cash equivalents is now -78.94% below its all-time high of $157.54 million, reached on 30 September 2022.ABOS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.6% | -65.0% |
| 3 y3 years | +52.8% | -75.6% |
| 5 y5 years | - | - |
ABOS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -48.6% | +52.8% | -78.9% | at low |
| 5 y | 5 years | -48.6% | +920.9% | -78.9% | at low |
| alltime | all time | -48.6% | +920.9% | -78.9% | at low |
Acumen Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $33.18 M(-51.2%) |
| June 2024 | - | $67.95 M(+44.8%) |
| Mar 2024 | - | $46.93 M(-29.8%) |
| Dec 2023 | $66.89 M(-48.6%) | $66.89 M(-29.5%) |
| Sept 2023 | - | $94.92 M(+22.9%) |
| June 2023 | - | $77.25 M(-1.0%) |
| Mar 2023 | - | $78.00 M(-40.0%) |
| Dec 2022 | $130.10 M | $130.10 M(-17.4%) |
| Sept 2022 | - | $157.54 M(+41.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $111.07 M(+2.1%) |
| Mar 2022 | - | $108.76 M(-11.0%) |
| Dec 2021 | $122.16 M(+179.1%) | $122.16 M(-10.0%) |
| Sept 2021 | - | $135.80 M(+97.4%) |
| June 2021 | - | $68.81 M(+66.2%) |
| Mar 2021 | - | $41.41 M(-5.4%) |
| Dec 2020 | $43.78 M(+568.1%) | - |
| Dec 2020 | - | $43.78 M |
| Dec 2019 | $6.55 M | - |
FAQ
- What is Acumen Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Acumen Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Acumen Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ABOS is $66.89 M
What is the all time high annual cash & cash equivalents for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual cash & cash equivalents is $130.10 M
What is Acumen Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ABOS annual cash & cash equivalents has changed by -$63.22 M (-48.59%)
What is Acumen Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ABOS is $33.18 M
What is the all time high quarterly cash and cash equivalents for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly cash and cash equivalents is $157.54 M
What is Acumen Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ABOS quarterly cash and cash equivalents has changed by -$61.73 M (-65.04%)